PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION

PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION

Disclosed is a pharmaceutical composition comprising the following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte, all of which are contained in the pharmaceutical composition in the proliferated and activated state. A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: KURAMOCHI TSUNEO
Format: Patent
Sprache:eng ; kor
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KURAMOCHI TSUNEO
description Disclosed is a pharmaceutical composition comprising the following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte, all of which are contained in the pharmaceutical composition in the proliferated and activated state. Also disclosed is a method for producing the pharmaceutical composition. The following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte can be proliferated and activated almost simultaneously, readily and efficiently, by charging a peripheral blood lymphocyte mixture isolated from a peripheral blood and a lymphocyte culture medium containing interleukin-2 into a culture vessel having both of an anti-human CD3 monoclonal antibody and an anti-human CD161 monoclonal antibody immobilized thereon, and culturing the mixed solution in the culture vessel.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20100083838A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20100083838A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20100083838A3</originalsourceid><addsrcrecordid>eNrjZAgK8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw9HNR8HUN8fB3UXDzD1IICPJ3CXUGy_i7KeDWx8PAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4r2DjAwMDQwMLIyB0NGYOFUAwC8w3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION</title><source>esp@cenet</source><creator>KURAMOCHI TSUNEO</creator><creatorcontrib>KURAMOCHI TSUNEO</creatorcontrib><description>Disclosed is a pharmaceutical composition comprising the following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte, all of which are contained in the pharmaceutical composition in the proliferated and activated state. Also disclosed is a method for producing the pharmaceutical composition. The following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte can be proliferated and activated almost simultaneously, readily and efficiently, by charging a peripheral blood lymphocyte mixture isolated from a peripheral blood and a lymphocyte culture medium containing interleukin-2 into a culture vessel having both of an anti-human CD3 monoclonal antibody and an anti-human CD161 monoclonal antibody immobilized thereon, and culturing the mixed solution in the culture vessel.</description><language>eng ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100722&amp;DB=EPODOC&amp;CC=KR&amp;NR=20100083838A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100722&amp;DB=EPODOC&amp;CC=KR&amp;NR=20100083838A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KURAMOCHI TSUNEO</creatorcontrib><title>PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION</title><description>Disclosed is a pharmaceutical composition comprising the following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte, all of which are contained in the pharmaceutical composition in the proliferated and activated state. Also disclosed is a method for producing the pharmaceutical composition. The following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte can be proliferated and activated almost simultaneously, readily and efficiently, by charging a peripheral blood lymphocyte mixture isolated from a peripheral blood and a lymphocyte culture medium containing interleukin-2 into a culture vessel having both of an anti-human CD3 monoclonal antibody and an anti-human CD161 monoclonal antibody immobilized thereon, and culturing the mixed solution in the culture vessel.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAgK8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw9HNR8HUN8fB3UXDzD1IICPJ3CXUGy_i7KeDWx8PAmpaYU5zKC6W5GZTdXEOcPXRTC_LjU4sLEpNT81JL4r2DjAwMDQwMLIyB0NGYOFUAwC8w3A</recordid><startdate>20100722</startdate><enddate>20100722</enddate><creator>KURAMOCHI TSUNEO</creator><scope>EVB</scope></search><sort><creationdate>20100722</creationdate><title>PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION</title><author>KURAMOCHI TSUNEO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20100083838A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KURAMOCHI TSUNEO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KURAMOCHI TSUNEO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION</title><date>2010-07-22</date><risdate>2010</risdate><abstract>Disclosed is a pharmaceutical composition comprising the following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte, all of which are contained in the pharmaceutical composition in the proliferated and activated state. Also disclosed is a method for producing the pharmaceutical composition. The following two types of cells: an NK cell and a lymphocyte, or the following three types of cells: an NKT cell, an NK cell and a lymphocyte can be proliferated and activated almost simultaneously, readily and efficiently, by charging a peripheral blood lymphocyte mixture isolated from a peripheral blood and a lymphocyte culture medium containing interleukin-2 into a culture vessel having both of an anti-human CD3 monoclonal antibody and an anti-human CD161 monoclonal antibody immobilized thereon, and culturing the mixed solution in the culture vessel.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; kor
recordid cdi_epo_espacenet_KR20100083838A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A15%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KURAMOCHI%20TSUNEO&rft.date=2010-07-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20100083838A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true